Integrative pan-cancer analysis of UCP family and experimental validation identifies UCP2 as a potential therapeutic target for gliomaAuthorsJunru Chen (ORCID: https://orcid.org/0000-0003-4553-6979)Shan Li (ORCID: https://orcid.org/0000-0002-1776-2592)Xianghua Zeng (ORCID: https://orcid.org/0009-0003-2588-9248)Xun Wu (ORCID: https://orcid.org/0000-0002-8213-3178)Wen Zhi GuoInstitutionsMianyang Central Hospital (CN)Affiliated Hospital of North Sichuan Medical College (CN)Chengdu Fifth People's Hospital (CN)Lanzhou University (CN)Publication DetailsJournalFrontiers in Cell and Developmental BiologyPublished2025-12-01DOIhttps://doi.org/10.3389/fcell.2025.1662654Primary TopicUbiquitin and proteasome pathwaysTypearticleField-Weighted Citation Impact0.00Explore the Global Research Space Interactive Map